Publicacións en colaboración con investigadores/as de Hospital Universitario La Paz (46)

2024

  1. Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application

    Journal of Experimental and Clinical Cancer Research, Vol. 43, Núm. 1

2021

  1. Impact of recommended maternal vaccination programs on the clinical presentation of sars-cov-2 infection: A prospective observational study

    Vaccines, Vol. 9, Núm. 1, pp. 1-10

  2. M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patients

    Gynecologic Oncology, Vol. 161, Núm. 3, pp. 681-686

  3. Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women

    Viruses, Vol. 13, Núm. 1

  4. Perinatal outcomes of pregnancies resulting from assisted reproduction technology in SARS-CoV-2-infected women: a prospective observational study

    Fertility and Sterility, Vol. 116, Núm. 3, pp. 731-740

  5. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11–13 weeks' gestation: data from EVENTS trial

    Ultrasound in Obstetrics and Gynecology, Vol. 57, Núm. 2, pp. 257-265

  6. The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysis

    BMC Pregnancy and Childbirth, Vol. 21, Núm. 1

2020

  1. High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak

    International Journal of Dermatology, Vol. 59, Núm. 12, pp. 1475-1484

2018

  1. Facial spiny follicular hyperkeratosis induced by vemurafenib

    Journal of Dermatology

2017

  1. A fatal drug interaction

    Medicina Clinica, Vol. 149, Núm. 9, pp. e47

  2. Genetic 3′UTR variation is associated with human pigmentation characteristics and sensitivity to sunlight

    Experimental Dermatology, Vol. 26, Núm. 10, pp. 896-903

  3. Patrones dermatoscópicos de tumores no melanocíticos

    Piel, Vol. 32, Núm. 5, pp. 298-304

  4. Subacute cutaneous lupus erythematosus induced by masitinib

    International Journal of Dermatology, Vol. 56, Núm. 11, pp. 1180-1181

2016

  1. Subacute cutaneous lupus erythematosus induced by mitotane

    JAMA Dermatology

  2. Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: A pilot clinical trial

    AIDS, Vol. 30, Núm. 1, pp. 75-82

2015

  1. Adherence to drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne: The ACTUO observational prospective multicenter cohort trial in 643 patients

    BMC Dermatology, Vol. 15, Núm. 1

  2. Assessment of morbidity in gynaecologic oncology laparoscopy and identification of possible risk factors

    ecancermedicalscience, Vol. 9

  3. Diffuse reactive angioendotheliomatosis secondary to the administration of trabectedin and pegfilgrastim

    American Journal of Dermatopathology, Vol. 37, Núm. 7, pp. 581-584

  4. Frequency and characteristics of familial melanoma in Spain: The FAM-GEM-1 study

    PLoS ONE, Vol. 10, Núm. 4

  5. Herpes zoster: A potential risk associated with fingolimod treatment

    International Journal of Dermatology